COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Analytical Development Services

The highly experienced analytical development team covers a wide range of analytical methods from small molecule analysis through to cell killing assays and ELISA development.

We support the analytical development, validation, and quality control release testing needed to get ADC or bioconjugate to clinic or market, all at one location. We also offer method development and testing to characterize ADC or bioconjugate in all vital quality attributes.

Analytical Development and Validation

  • Method development for HPLC (HIC, SEC, PLRP), icIEF, CE-SDS, SDS-PAGE, ELISA, Cell-Based Assays, and cleaning methods
  • Qualification/Validation or Transfer of Methods
  • Commercialization activities support

Drug Substance and drug product release and stability testing

  • State-of-the-art onsite quality control laboratory
  • Over 15 years’ experience of routine screening of ADCs, including cell based assays and ELISA
  • Toxicology, Bulk Drug Substance and Finished Drug Product release testing
  • Stability testing to ICH guidelines